Withania somnifera (Indian ginseng) in diabetes mellitus: A systematic review and meta‐analysis of scientific evidence from experimental research to clinical application

Sharanbasappa Durg,Sachin Bavage,Shivakumar B. Shivaram
DOI: https://doi.org/10.1002/ptr.6589
IF: 6.388
2020-01-23
Phytotherapy Research
Abstract:<p><i>Withania somnifera</i> Dunal, also known as Indian ginseng, has been in use since ancient times in the management of diabetes mellitus (DM). This systematic review and meta‐analysis evaluated the efficacy/effectiveness, safety and tolerability of <i>W. somnifera</i> in managing DM. Literature search (published/unpublished) was performed from inception to April 2019 in guidelines recommended databases. A total of 6 in‐vitro, 13 pre‐clinical and 5 clinical studies were included for systematic evaluation. <i>W. somnifera</i> treatment in DM significantly restored the altered levels of blood glucose (experimental data; mean difference, −196.27; 95% confidence interval [−220.96, −171.58]; <i>p</i> &lt; .00001) glycosylated haemoglobin (HbA1c), insulin, lipid profile, serum and oxidative stress markers with no safety concerns. The results suggest the potential role of <i>W. somnifera</i> in managing DM. However, the available clinical data are not considerably enough to provide novel and sufficiently robust evidence for the use of <i>W. somnifera</i> in managing DM. To further strength the anti‐diabetic profile of <i>W. somnifera</i>, well‐designed randomized‐controlled trial(s) with a larger sample size and longer duration is warranted with evaluation of its effect primarily on blood glucose, HbA1c and insulin. Future research also needs to elucidate the molecular mechanism(s) of <i>W. somnifera</i> including its active principles in DM.</p>
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?